Silicone gel sheet to improve cosmetic outcome of the scar after removal of an implantable central venous access device in childhood cancer survivors

Completed

• Conditions: Hypertrophic scarring; Signs and Symptoms; Scarring

• Registration Number: ISRCTN77132184
• Lead Sponsor: Vrije University Medical Centre (VUMC) (The Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2006-12-28
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

1. Children who are in follow-up for cancer treatment, and have an ICVAD, which is planned to be removed, are eligible for the study
2. The children should be between one and eighteen years old

Exclusion Criteria

Children are excluded for the study when they had an ICVAD on an other location than the chest wall, when the ICVAD was removed because of an infection, or when the child received radiotherapy on the chest. This latter criterion is because of the damage to the skin during radiotherapy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified